Israel: Israel Chemicals (ICL) is selling its gypsum, pharmaceutical and cosmetics (PCG) business to One Rock Capital Partners for an estimated US$50m.
The sale of the PCG business units is part of ICL's 'Next Step Forward' strategy to divest its non-core businesses to focus on its core businesses in the agriculture, food and engineered materials markets. Israel Chemicals Performance Products' gypsum business is mostly in the UK and focuses on dental applications.
